Letters to the Editor

Tofacitinib as a novel therapeutic option for refractory Schnitzler's syndrome: a case report

H. Wang¹, J. Xu², J. Tang³, X. Wu⁴

Department of Rheumatology, the First Affiliated Hospital of Ningbo University, Ningbo, China.
Department of Haematology and Oncology, Ningbo No. 2 Hospital, Ningbo, China.
Department of Haematology and Oncology, Ningbo No. 2 Hospital, Ningbo, China.
Department of Rheumatology, the First Affiliated Hospital of Ningbo University, Ningbo, China. wuxiudinbey@163.com

CER19522
Letters to the Editor

Free to view
(click on article PDF icon to read the article)

Received: 12/11/2025
Accepted : 30/01/2026
In Press: 06/05/2026